Banner

Article

Treating pain: Can doctors put their fears to rest?

The medical use of controlled substances has gained new legitimacy. But physicians' dread of regulatory scrutiny lingers.

Related Videos
Related Content
© burdun - stock.adobe.com
April 23rd 2025

U.S. dementia costs to reach $781 billion in 2025 — who’s really paying for it

Off the Chart: A Business of Medicine Podcast - Ep. 61: Prior authorization with Heather Bassett, MD
April 21st 2025

Ep. 61: Prior authorization with Heather Bassett, MD

Merger to boost RPM technology: ©Metamorworks - stock.adobe.com
April 23rd 2025

Validic and Tenovi join forces to expand access to remote patient monitoring

Off the Chart: A Business of Medicine Podcast - Ep. 60: Strategic planning with Stephen A. Dickens of SVMIC
April 14th 2025

Ep. 60: Strategic planning with Stephen A. Dickens of SVMIC

FDA approves epilepsy device: ©Drmicrobe - stock.adobe.com
April 23rd 2025

FDA grants Breakthrough approval for Epiminder’s Implantable EEG System for epilepsy monitoring

© meeboonstudio - stock.adobe.com
April 23rd 2025

U.S. cancer deaths still declining; NJ marketers sentenced in $127M Medicare kickback scheme; middle-aged Americans among the loneliest in the world – Morning Medical Update